{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T10:40:14Z","timestamp":1731235214945,"version":"3.28.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,10]]},"DOI":"10.7759\/cureus.73365","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T10:25:41Z","timestamp":1731234341000},"source":"Crossref","is-referenced-by-count":0,"title":["Pericardial Effusion as a Presentation of Lymphangioleiomyomatosis"],"prefix":"10.7759","author":[{"given":"Martinha","family":"Vale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraia","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Esperan\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack FX","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, et al.. Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016, 194:748-61. 10.1164\/rccm.201607-1384ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0007-2020","article-title":"Lymphangioleiomyomatosis: a clinical review","volume":"16","author":"O'Mahony AM","year":"2020","unstructured":"O'Mahony AM, Lynn E, Murphy DJ, Fabre A, McCarthy C. Lymphangioleiomyomatosis: a clinical review. Breathe (Sheff). 2020, 16:200007. 10.1183\/20734735.0007-2020","journal-title":"Breathe (Sheff)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson SR","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, et al.. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010, 35:14-26. 10.1183\/09031936.00076209","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0042-2017","article-title":"New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis","volume":"26","author":"Torre O","year":"2017","unstructured":"Torre O, Elia D, Caminati A, Harari S. New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017, 26:170042. 10.1183\/16000617.0042-2017","journal-title":"Eur Respir Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2022.02.075","article-title":"Pulmonary lymphangioleiomyomatosis (LAM): a literature overview and case report","volume":"17","author":"Cong CV","year":"2022","unstructured":"Cong CV, Anh TT, Ly TT, Duc NM. Pulmonary lymphangioleiomyomatosis (LAM): a literature overview and case report. Radiol Case Rep. 2022, 17:1646-55. 10.1016\/j.radcr.2022.02.075","journal-title":"Radiol Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43513","article-title":"The epidemiology and clinical features of lymphangioleiomyomatosis (LAM): a descriptive study of 33 case reports","volume":"15","author":"Shah JM","year":"2023","unstructured":"Shah JM, Patel JT, Shah H, Dadigiri H, Alla A, Cheriyath P. The epidemiology and clinical features of lymphangioleiomyomatosis (LAM): a descriptive study of 33 case reports. Cureus. 2023, 15:e43513. 10.7759\/cureus.43513","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy C","year":"2021","unstructured":"McCarthy C, Gupta N, Johnson SR, Yu JJ, McCormack FX. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med. 2021, 9:1313-27. 10.1016\/S2213-2600(21)00228-9","journal-title":"Lancet Respir Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201709-1965ST","article-title":"Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An official American Thoracic Society\/Japanese Respiratory Society clinical practice guideline","volume":"196","author":"Gupta N","year":"2017","unstructured":"Gupta N, Finlay GA, Kotloff RM, et al.. Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An official American Thoracic Society\/Japanese Respiratory Society clinical practice guideline. Am J Respir Crit Care Med. 2017, 196:1337-48. 10.1164\/rccm.201709-1965ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.090525","article-title":"Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells","volume":"175","author":"Klarquist J","year":"2009","unstructured":"Klarquist J, Barfuss A, Kandala S, et al.. Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. Am J Pathol. 2009, 175:2463-72. 10.2353\/ajpath.2009.090525","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack FX","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, et al.. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011, 364:1595-606. 10.1056\/NEJMoa1100391","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02370-2019","article-title":"Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial","volume":"55","author":"El-Chemaly S","year":"2020","unstructured":"El-Chemaly S, Taveira-DaSilva A, Bagwe S, et al.. Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial. Eur Respir J. 2020, 55:1902370. 10.1183\/13993003.02370-2019","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105898","article-title":"A phase II clinical trial of the safety of simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex","volume":"163","author":"Krymskaya VP","year":"2020","unstructured":"Krymskaya VP, Courtwright AM, Fleck V, Dorgan D, Kotloff R, McCormack FX, Kreider M. A phase II clinical trial of the safety of simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex. Respir Med. 2020, 163:105898. 10.1016\/j.rmed.2020.105898","journal-title":"Respir Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.01.033","article-title":"Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a phase I clinical trial","volume":"151","author":"El-Chemaly S","year":"2017","unstructured":"El-Chemaly S, Taveira-Dasilva A, Goldberg HJ, et al.. Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a phase I clinical trial. Chest. 2017, 151:1302-10. 10.1016\/j.chest.2017.01.033","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.06.015","article-title":"Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis","volume":"38","author":"Khawar MU","year":"2019","unstructured":"Khawar MU, Yazdani D, Zhu Z, Jandarov R, Dilling DF, Gupta N. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis. J Heart Lung Transplant. 2019, 38:949-55. 10.1016\/j.healun.2019.06.015","journal-title":"J Heart Lung Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315099-pericardial-effusion-as-a-presentation-of-lymphangioleiomyomatosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T10:25:43Z","timestamp":1731234343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315099-pericardial-effusion-as-a-presentation-of-lymphangioleiomyomatosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,10]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.73365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,10]]}}}